
Diclofenac (50mg) + Serratiopeptidase (10mg) + Paracetamol (325mg)
Active composition
+2 more active ingredients
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Xeroflam-S Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides additional analgesic and antipyretic benefits through central inhibition of prostaglandin synthesis, enhancing pain relief while minimizing gastrointestinal side effects commonly associated with NSAIDs. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting fibrinolysis, which aids in the resolution of swelling and pain. This synergistic combination is indicated for the management of acute musculoskeletal disorders, postoperative pain, osteoarthritis, rheumatoid arthritis, and other inflammatory conditions requiring effective pain control and inflammation reduction. Xeroflam-S is typically administered orally and should be used under medical supervision, especially in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, or hypersensitivity to any component. Caution is advised during pregnancy and lactation. Adverse effects may include gastrointestinal discomfort, allergic reactions, and rarely, hepatic or renal dysfunction. Proper dosage adherence and monitoring are essential to maximize therapeutic benefits and minimize risks.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Xeroflam-S Tablet

Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Xeroflam-S Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides additional analgesic and antipyretic benefits through central inhibition of prostaglandin synthesis, enhancing pain relief while minimizing gastrointestinal side effects commonly associated with NSAIDs. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting fibrinolysis, which aids in the resolution of swelling and pain. This synergistic combination is indicated for the management of acute musculoskeletal disorders, postoperative pain, osteoarthritis, rheumatoid arthritis, and other inflammatory conditions requiring effective pain control and inflammation reduction. Xeroflam-S is typically administered orally and should be used under medical supervision, especially in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, or hypersensitivity to any component. Caution is advised during pregnancy and lactation. Adverse effects may include gastrointestinal discomfort, allergic reactions, and rarely, hepatic or renal dysfunction. Proper dosage adherence and monitoring are essential to maximize therapeutic benefits and minimize risks.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Xeroflam-S Tablet











